Search - tctmd.com

Displaying 1 - 20 of 121

Sort: Relevancy | Date

News Daily News

FDA Approves Bioresorbable Scaffold for BTK Lesions

Michael O'Riordan

April 29, 2024

News Daily News

BASIL-3: More Questions Than Answers About Drug-Coated Devices in CLTI

L.A. McKeown

April 24, 2024

News Conference News ACC 2024

IVUS Benefits Patients Receiving DCBs for Fem-Pop Disease

Caitlin E. Cox

April 10, 2024

Presentation ACC 2024

Comparison of IVUS-guided vs. Angiography-guided Angioplasty for the Outcomes of DCB in the Treatment of Femoropopliteal Artery Disease

Presenter: Young-Guk Ko

April 08, 2024

News Daily News

DETECT: No Long-term Harm From Paclitaxel Devices in PAD

L.A. McKeown

March 25, 2024

News Daily News

Top Endovascular News of 2023

L.A. McKeown

December 28, 2023

News Conference News TCT 2023

LIFE-BTK: Bioresorbable Scaffold Holds Promise for Infrapopliteal CLTI

L.A. McKeown

October 25, 2023

News Daily News

Radial Access Is Safe, Effective for Peripheral Interventions: R2P Registry

Todd Neale

October 16, 2023

News Conference News LINC 2023

PROSPECT MONSTER: Real-World Data Confirm Low-Dose DCB Efficacy in PAD

L.A. McKeown

June 21, 2023

News Conference News LINC 2023

Early Data on Temporary Spur in BTK PAD Show Efficacy, Limited Recoil

L.A. McKeown

June 09, 2023

News Conference News ISET 2023

BioMimics 3D Stent Holds Up Well at 3 Years in Complex PAD Lesions

Caitlin E. Cox

January 20, 2023

News Daily News

Top Endovascular News of 2022

L.A. McKeown

January 03, 2023

News Features

Does BEST-CLI Settle the Surgery vs Endovascular Question for CLTI?

L.A. McKeown

December 02, 2022

News Conference News

Paclitaxel Safety Concerns Wane as Hope Emerges for Newer PAD Devices

L.A. McKeown

November 18, 2022

News Conference News AHA 2022

Long-Awaited BEST-CLI Results Favor Surgery Over Endovascular Therapy in CLTI

L.A. McKeown

November 07, 2022

News Daily News

Worse Complications After PVI in Women Highlight Research Gaps

L.A. McKeown

August 16, 2022

News Opinion CV Team Dispatch

August 2022 News Roundup

L.A. McKeown

August 01, 2022

News Daily News

High Lp(a) May Predict Risk of CV and Limb Events in PAD

L.A. McKeown

July 18, 2022

News Conference News SCAI 2022

DISRUPT PAD III: Lithotripsy Prep Linked to Better PAD Patency at 1 Year

L.A. McKeown

May 23, 2022

News Daily News

Routine IVUS in Peripheral Interventions Supported by Small RCT

L.A. McKeown

March 09, 2022

Advertisement

FDA Approves Bioresorbable Scaffold for BTK Lesions

BASIL-3: More Questions Than Answers About Drug-Coated Devices in CLTI

IVUS Benefits Patients Receiving DCBs for Fem-Pop Disease

Comparison of IVUS-guided vs. Angiography-guided Angioplasty for the Outcomes of DCB in the Treatment of Femoropopliteal Artery Disease

DETECT: No Long-term Harm From Paclitaxel Devices in PAD

Top Endovascular News of 2023

LIFE-BTK: Bioresorbable Scaffold Holds Promise for Infrapopliteal CLTI

Radial Access Is Safe, Effective for Peripheral Interventions: R2P Registry

PROSPECT MONSTER: Real-World Data Confirm Low-Dose DCB Efficacy in PAD

Early Data on Temporary Spur in BTK PAD Show Efficacy, Limited Recoil

BioMimics 3D Stent Holds Up Well at 3 Years in Complex PAD Lesions

Top Endovascular News of 2022

Does BEST-CLI Settle the Surgery vs Endovascular Question for CLTI?

Paclitaxel Safety Concerns Wane as Hope Emerges for Newer PAD Devices

Long-Awaited BEST-CLI Results Favor Surgery Over Endovascular Therapy in CLTI

Worse Complications After PVI in Women Highlight Research Gaps

August 2022 News Roundup

High Lp(a) May Predict Risk of CV and Limb Events in PAD

DISRUPT PAD III: Lithotripsy Prep Linked to Better PAD Patency at 1 Year

Routine IVUS in Peripheral Interventions Supported by Small RCT

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content